NasdaqGS:ASNDBiotechs
Assessing Ascendis Pharma (ASND) Valuation After Recent Share Price Uptick And Ongoing Losses
Ascendis Pharma (NasdaqGS:ASND) is back on investor radars after a recent daily move of about 1.9%, with the stock closing at US$229.27. That shift is now being weighed against its fundamentals.
See our latest analysis for Ascendis Pharma.
The 1.9% one day share price return contrasts with a year to date share price return of a 6.6% decline, which hints at some short term momentum rebuilding after earlier weakness.
If Ascendis Pharma’s move has you thinking about where else growth stories...